Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans

Published on Jun 21, 2019in Journal of Bone and Mineral Research5.854
· DOI :10.1002/JBMR.3729
Joshua N. Farr28
Estimated H-index: 28
(Mayo Clinic),
Jennifer L. Rowsey3
Estimated H-index: 3
(Mayo Clinic)
+ 6 AuthorsSundeep Khosla130
Estimated H-index: 130
(Mayo Clinic)
: Estrogen deficiency is a seminal mechanism in the pathogenesis of osteoporosis. Mounting evidence, however, establishes that cellular senescence, a fundamental mechanism that drives multiple age-related diseases, also causes osteoporosis. Recently, we systematically identified an accumulation of senescent cells, characterized by increased p16Ink4a and p21Cip1 levels and development of a senescence-associated secretory phenotype (SASP), in mouse bone/marrow and human bone with aging. We then demonstrated that elimination of senescent cells prevented age-related bone loss using multiple approaches, eg, treating old mice expressing a "suicide" transgene, INK-ATTAC, with AP20187 to induce apoptosis of p16Ink4a -senescent cells or periodically treating old wild-type mice with "senolytics," ie, drugs that eliminate senescent cells. Here, we investigate a possible role for estrogen in the regulation of cellular senescence using multiple approaches. First, sex steroid deficiency 2 months after ovariectomy (OVX, n = 15) or orchidectomy (ORCH, n = 15) versus sham surgery (SHAM, n = 15/sex) in young adult (4-month-old) wild-type mice did not alter senescence biomarkers or induce a SASP in bone. Next, in elderly postmenopausal women, 3 weeks of estrogen therapy (n = 10; 74 ± 5 years) compared with no treatment (n = 10; 78 ± 5 years) did not alter senescence biomarkers or the SASP in human bone biopsies. Finally, young adult (4-month-old) female INK-ATTAC mice were randomized (n = 17/group) to SHAM+Vehicle, OVX+Vehicle, or OVX+AP20187 for 2 months. As anticipated, OVX+Vehicle caused significant trabecular/cortical bone loss compared with SHAM+Vehicle. However, treatment with AP20187, which eliminates senescent cells in INK-ATTAC mice, did not rescue the OVX-induced bone loss or alter senescence biomarkers. Collectively, our data establish independent roles of estrogen deficiency and cellular senescence in the pathogenesis of osteoporosis, which has important implications for testing novel senolytics for skeletal efficacy, as these drugs will need to be evaluated in preclinical models of aging as opposed to the current FDA model of prevention of OVX-induced bone loss. © 2019 American Society for Bone and Mineral Research.
Figures & Tables
📖 Papers frequently viewed together
1 Author (康一 篠原)
5 Authors (Sandi Raehtz, ..., Laura R. McCabe)
19 Citations
3 Citations
#1Joshua N. Farr (Mayo Clinic)H-Index: 28
#2Sundeep Khosla (Mayo Clinic)H-Index: 130
Abstract Cellular senescence refers to a process induced by various types of stress that causes irreversible cell cycle arrest and distinct cellular alterations, including profound changes in gene expression, metabolism, and chromatin organization as well as activation/reinforcement of anti-apoptotic pathways and development of a pro-inflammatory secretome or senescence-associated secretory phenotype (SASP). However, because of challenges and technical limitations in identifying and characterizi...
44 CitationsSource
#1Walter A. Rocca (Mayo Clinic)H-Index: 111
#2Liliana Gazzuola Rocca (Mayo Clinic)H-Index: 7
Last. Virginia M. Miller (Mayo Clinic)H-Index: 72
view all 13 authors...
Bilateral oophorectomy in premenopausal women is a unique condition causing the abrupt and premature loss of ovarian hormones, primarily estrogen. Bilateral oophorectomy causes an alteration of sev...
15 CitationsSource
: Aging research has undergone unprecedented advances at an accelerating rate in recent years, leading to excitement in the field as well as opportunities for imagination and innovation. Novel insights indicate that, rather than resulting from a preprogrammed series of events, the aging process is predominantly driven by fundamental non-adaptive mechanisms that are interconnected, linked, and overlap. To varying degrees, these mechanisms also manifest with aging in bone where they cause skeletal...
23 CitationsSource
#1Ming Xu (UConn: University of Connecticut)H-Index: 28
#2Tamar Pirtskhalava (Mayo Clinic)H-Index: 28
Last. James L. Kirkland (Mayo Clinic)H-Index: 78
view all 33 authors...
Physical function declines in old age, portending disability, increased health expenditures, and mortality. Cellular senescence, leading to tissue dysfunction, may contribute to these consequences of aging, but whether senescence can directly drive age-related pathology and be therapeutically targeted is still unclear. Here we demonstrate that transplanting relatively small numbers of senescent cells into young mice is sufficient to cause persistent physical dysfunction, as well as to spread cel...
620 CitationsSource
#1Sundeep Khosla (Mayo Clinic)H-Index: 130
#2Joshua N. Farr (Mayo Clinic)H-Index: 28
Last. James L. Kirkland (Mayo Clinic)H-Index: 78
view all 3 authors...
Context:With the aging of the population and projected increase in osteoporotic fractures coupled with the declining use of osteoporosis medications, there is a compelling need for new approaches to treat osteoporosis. Given that age-related osteoporosis generally coexists with multiple other comorbidities (e.g., atherosclerosis, diabetes, frailty) that share aging as the leading risk factor, there is growing interest in the "Geroscience Hypothesis," which posits that manipulation of fundamental...
62 CitationsSource
: Osteoporosis is a significant public health problem, and a major cause of the disease is estrogen deficiency following menopause in women. In addition, considerable evidence now shows that estrogen is also a major regulator of bone metabolism in men. Since the original description of the effects of estrogen deficiency on bone by Fuller Albright more than 70 years ago, there has been enormous progress in understanding the mechanisms of estrogen and testosterone action on bone using human and mo...
65 CitationsSource
#1Marilina Piemontese (University of Arkansas for Medical Sciences)H-Index: 16
#2Maria Almeida (University of Arkansas for Medical Sciences)H-Index: 42
Last. Robert L. Jilka (University of Arkansas for Medical Sciences)H-Index: 69
view all 10 authors...
: Decreased cortical thickness and increased cortical porosity are the key anatomic changes responsible for osteoporotic fractures in elderly women and men. The cellular basis of these changes is unbalanced endosteal and intracortical osteonal remodeling by the osteoclasts and osteoblasts that comprise the basic multicellular units (BMUs). Like humans, mice lose cortical bone with age, but unlike humans, this loss occurs in the face of sex steroid sufficiency. Mice are therefore an ideal model t...
76 CitationsSource
#1Joshua N. Farr (Mayo Clinic)H-Index: 28
#2Ming Xu (Mayo Clinic)H-Index: 28
Last. Sundeep KhoslaH-Index: 130
view all 18 authors...
Genetic or pharmacological depletion of senescent cells or inhibition of their function reduces bone loss in aged mice.
367 CitationsSource
#1Walter A. Rocca (Mayo Clinic)H-Index: 111
#2Liliana Gazzuola Rocca (Mayo Clinic)H-Index: 7
Last. Virginia M. Miller (Mayo Clinic)H-Index: 72
view all 9 authors...
Background: The cause-effect relationship between bilateral oophorectomy and accelerated aging remains controversial. We conducted new analyses to further address this controversy. Methods: The Rochester Epidemiology Project records-linkage system was used to identify all premenopausal women who underwent bilateral oophorectomy for a noncancerous condition before age 50 years between 1988 and 2007 in Olmsted County, MN. Each woman was randomly matched to a referent woman born in the same year (±...
48 CitationsSource
#1Ha-Neui Kim (University of Arkansas for Medical Sciences)H-Index: 23
#2Jianhui Chang (University of Arkansas for Medical Sciences)H-Index: 17
Last. Maria Almeida (University of Arkansas for Medical Sciences)H-Index: 42
view all 10 authors...
Summary Age-related bone loss in mice results from a decrease in bone formation and an increase in cortical bone resorption. The former is accounted by a decrease in the number of postmitotic osteoblasts which synthesize the bone matrix and is thought to be the consequence of age-dependent changes in mesenchymal osteoblast progenitors. However, there are no specific markers for these progenitors, and conclusions rely on results from in vitro cultures of mixed cell populations. Moreover, the culp...
87 CitationsSource
Cited By25
#1Mei Wan (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 33
#2Elise F Gray-Gaillard (Johns Hopkins University)
Last. Jennifer H. Elisseeff (Johns Hopkins University)H-Index: 78
view all 3 authors...
Emerging insights into cellular senescence highlight the relevance of senescence in musculoskeletal disorders, which represent the leading global cause of disability. Cellular senescence was initially described by Hayflick et al. in 1961 as an irreversible nondividing state in in vitro cell culture studies. We now know that cellular senescence can occur in vivo in response to various stressors as a heterogeneous and tissue-specific cell state with a secretome phenotype acquired after the initial...
#1Madison L. Doolittle (Mayo Clinic)H-Index: 1
#2David G. Monroe (Mayo Clinic)H-Index: 28
Last. Sundeep Khosla (Mayo Clinic)H-Index: 130
view all 4 authors...
The skeletal system undergoes irreversible structural deterioration with aging, leading to increased fracture risk and detrimental changes in mobility, posture, and gait. This state of low bone mass and microarchitectural changes, diagnosed as osteoporosis, affects millions of individuals worldwide and has high clinical and economic burdens. Recently, pre-clinical studies have linked the onset of age-related bone loss with an accumulation of senescent cells in the bone microenvironment. These se...
How ageing contributes to bone loss is unclear. In ageing mice, skeletal stem cells lose their ability to generate bone-forming cells called osteoblasts, and instead promote the generation of bone-resorbing cells called osteoclasts. null With age, skeletal stem cells generate fewer bone-forming cells.
#1Wei-Shiung Lian (CGU: Chang Gung University)H-Index: 7
#2Re-Wen Wu (CGU: Chang Gung University)H-Index: 4
Last. Feng-Sheng Wang (CGU: Chang Gung University)H-Index: 40
view all 7 authors...
Senescent osteoblast overburden accelerates bone mass loss. Little is understood about microRNA control of oxidative stress and osteoblast senescence in osteoporosis. We revealed an association between microRNA-29a (miR-29a) loss, oxidative stress marker 8-hydroxydeoxyguanosine (8-OHdG), DNA hypermethylation marker 5-methylcystosine (5mC), and osteoblast senescence in human osteoporosis. miR-29a knockout mice showed low bone mass, sparse trabecular microstructure, and osteoblast senescence. miR-...
1 CitationsSource
#1Janja Zupan (University of Ljubljana)H-Index: 10
#2Klemen Strazar (University of Ljubljana)
Last. Darja Marolt PresenH-Index: 3
view all 6 authors...
Abstract null null The most common clinical manifestations of age-related musculoskeletal degeneration are osteoarthritis and osteoporosis, and these represent an enormous burden on modern society. Mesenchymal stromal cells (MSCs) have pivotal roles in musculoskeletal tissue development. In adult organisms, MSCs retain their ability to regenerate tissues following bone fractures, articular cartilage injuries, and other traumatic injuries of connective tissue. However, their remarkable regenerati...
#1Dominik Saul (Mayo Clinic)H-Index: 9
#2David G. Monroe (Mayo Clinic)H-Index: 28
Last. Sundeep Khosla (Mayo Clinic)H-Index: 130
view all 8 authors...
Senescent cells have detrimental effects across tissues with aging but may have beneficial effects on tissue repair, specifically on skin wound healing. However, the potential role of senescent cells in fracture healing has not been defined. Here, we performed an in silico analysis of public mRNAseq data and found that senescence and senescence-associated secretory phenotype (SASP) markers increased during fracture healing. We next directly established that the expression of senescence biomarker...
#1Robert J. Pignolo (Mayo Clinic)H-Index: 35
#2Susan F. Law (Mayo Clinic)H-Index: 1
Last. Abhishek Chandra (Mayo Clinic)H-Index: 16
view all 3 authors...
Changes in aging bone that lead to osteoporosis are mediated at multiple levels, including hormonal alterations, skeletal unloading, and accumulation of senescent cells. This pathological interplay is superimposed upon medical conditions, potentially bone-wasting medications, modifiable and unmodifiable personal risk factors, and genetic predisposition that accelerate bone loss with aging. In this study, the focus is on bone hemostasis and its dysregulation with aging. The major physiological ch...
4 CitationsSource
#1Abhishek Chandra (Mayo Clinic)H-Index: 16
#2Jyotika Rajawat (LU: University of Lucknow)H-Index: 1
Bone is a dynamic organ maintained by tightly regulated mechanisms. With old age, bone homeostasis, which is maintained by an intricate balance between bone formation and bone resorption, undergoes deregulation. Oxidative stress-induced DNA damage, cellular apoptosis, and cellular senescence are all responsible for this tissue dysfunction and the imbalance in the bone homeostasis. These cellular mechanisms have become a target for therapeutics to treat age-related osteoporosis. Genetic mouse mod...
2 CitationsSource
#1Sundeep Khosla (Mayo Clinic)H-Index: 130
#2Roberto Pacifici (Emory University)H-Index: 63
Abstract Estrogen deficiency is a pivotal cause of postmenopausal bone loss and contributes to age-related bone loss in both sexes. At the cellular level, estrogen acts on multiple cell types, including T cells. Estrogen deficiency is associated with increased production of tumor necrosis factor by bone marrow T cells, which augments receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis. Moreover, estrogen deficiency alters the regulatory cross talk between T cells and s...
2 CitationsSource
#1Michaël R. Laurent (Katholieke Universiteit Leuven)H-Index: 26
#2Evelien Gielen (Katholieke Universiteit Leuven)H-Index: 24
Last. Dirk Vanderschueren (Katholieke Universiteit Leuven)H-Index: 93
view all 4 authors...
Abstract Male gender is a protective factor against the development of osteoporosis but men face a higher refracture risk, higher mortality risk, and a higher treatment gap. Consequently, men contribute considerably to the disease burden of osteoporosis. This chapter aims to review recent advances in our understanding of the epidemiology of male osteoporosis, the reasons why osteoporosis and fractures are less common in men, how sex steroids (androgens and estrogens) and other factors regulate m...